Fominoben

Fominoben is a type of benzamide-based antitussive agent. Fominoben works by acting on the central nervous system to increase alveolar ventilation, thereby improving the blood oxygen levels in patients with pulmonary diseases (COLD) . Fominoben can bind to the benzodiazepine receptor binding sites in the brain and also has anti-anxiety and anti-convulsant effects. Fominoben can be used in research on hypoxemia.

Product Specifications

CAS Number

[18053-31-1]

UNSPSC

12352005

Target

GABA Receptor

Related Pathways

Membrane Transporter/Ion Channel; Neuronal Signaling

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Smiles

O=C(NC1=CC=CC(Cl)=C1CN(C)CC(N2CCOCC2)=O)C3=CC=CC=C3

Molecular Formula

C21H24ClN3O3

Molecular Weight

401.89

References & Citations

[1]Crawley JN, et al. Anxiolytic-like properties of fominoben. Eur J Pharmacol. 1984 Jan 27;97 (3-4) :277-81.|[2]Wieser O, Witzel K. Fominoben, ein neuartiges Atemtherapeutikum [Fominoben, a new respiratory drug]. Arzneimittelforschung. 1973 Feb;23:Suppl 2a:337-8. German.